ProUroCare Medical Company Insiders
PUMD Stock | USD 0.0002 0.00 0.00% |
ProUroCare Medical employs about 2 people. The company is managed by 5 executives with a total tenure of roughly 24 years, averaging almost 4.0 years of service per executive, having 0.4 employees per reported executive. Evaluation of ProUroCare Medical's management performance can provide insight into the firm performance.
Stanton Myrum CEO CEO and Director |
ProUroCare | Build AI portfolio with ProUroCare Stock |
ProUroCare Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.6095) % which means that it has lost $0.6095 on every $100 spent on assets. This is way below average. ProUroCare Medical's management efficiency ratios could be used to measure how well ProUroCare Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, ProUroCare Medical's Return On Equity is projected to slightly decrease based on the last few years of reporting. As of October 6, 2025, Total Assets is expected to decline to about 201.2 K. In addition to that, Net Tangible Assets is expected to decline to about (4.6 M)As of October 6, 2025, Net Loss is expected to decline to about (3.6 M)
ProUroCare Medical Workforce Comparison
ProUroCare Medical is regarded third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,948. ProUroCare Medical adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.
ProUroCare Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProUroCare Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProUroCare Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ProUroCare Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Barrett David M over three months ago Disposition of tradable shares by Barrett David M of ProUroCare Medical subject to Rule 16b-3 | ||
Thon Richard over a year ago Acquisition by Thon Richard of 60000 shares of ProUroCare Medical subject to Rule 16b-3 |
ProUroCare Medical Notable Stakeholders
A ProUroCare Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ProUroCare Medical often face trade-offs trying to please all of them. ProUroCare Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ProUroCare Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stanton Myrum | CEO and Director | Profile | |
Benjamin Banks | CEO Director | Profile | |
Alan Shuler | CFO and Secretary | Profile | |
RAC JD | Consultant | Profile | |
David MD | Consultant | Profile |
About ProUroCare Medical Management Performance
The success or failure of an entity such as ProUroCare Medical often depends on how effective the management is. ProUroCare Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ProUroCare management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ProUroCare management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (11.32) | (11.88) | |
Return On Capital Employed | 0.51 | 0.53 | |
Return On Assets | (11.32) | (11.88) | |
Return On Equity | 0.70 | 0.73 |
Please note, the presentation of ProUroCare Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ProUroCare Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ProUroCare Medical's management manipulating its earnings.
ProUroCare Medical Workforce Analysis
Traditionally, organizations such as ProUroCare Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ProUroCare Medical within its industry.ProUroCare Medical Manpower Efficiency
Return on ProUroCare Medical Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.5M | |
Net Loss Per Executive | 591.8K |
Complementary Tools for ProUroCare Stock analysis
When running ProUroCare Medical's price analysis, check to measure ProUroCare Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProUroCare Medical is operating at the current time. Most of ProUroCare Medical's value examination focuses on studying past and present price action to predict the probability of ProUroCare Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProUroCare Medical's price. Additionally, you may evaluate how the addition of ProUroCare Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |